June 15, 2020 / 1:39 PM / 2 months ago

BRIEF-Yichang Hec Changjiang Pharmaceutical Says Recombinant Human Insulin Injection Got Launch Approval

June 15 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd:

* RECOMBINANT HUMAN INSULIN INJECTION GETS APPROVAL FOR LAUNCH FROM CHINA NMPA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below